Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong(University of Birmingham), Piers Gaunt(University of Birmingham), Guruprasad P. Aithal(University of Nottingham), Darren Barton(National Institute for Health Research), Diana Hull(University of Birmingham), Richard Parker(University of Birmingham), Jonathan Hazlehurst(Oxford Centre for Diabetes, Endocrinology and Metabolism), Kathy Guo(NIHR Birmingham Liver Biomedical Research Unit), George Abouda(Hull Royal Infirmary), Mark Aldersley(St James's University Hospital), Deborah Stocken(Newcastle University), Stephen Gough(Churchill Hospital), Jeremy Tomlinson(Churchill Hospital), Rachel M. Brown(Queen Elizabeth Hospital Birmingham), Stefan G. Hübscher(University of Birmingham), Philip N. Newsome(Queen Elizabeth Hospital Birmingham)
The Lancet
November 20, 2015
Cited by 2,100Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis